A Trial of NT-I7 in COVID-19 (SPESELPIS)
Clinical trial NCT04501796 · TERMINATED
Trial details
- NCT number
- NCT04501796
- Sponsor
- NeoImmuneTech
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-27
- Primary completion
- 2021-07-21
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.